Espinoza Octavio 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Espinoza Octavio（CIK 1905248）在 1 家公司共报告 43 笔 SEC Form 4 内部人交易（最近一笔 2026-08-14）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 16,179 | $854,898 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 2,869 | $159,947 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 7,171 | $410,325 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 3,348 | $230,142 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 31,641 | $9.2M |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 2,074 | $145,263 |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 17 | $2,732 |
| 2026-05-28 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 764 | $48,606 |
| 2026-05-28 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 972 | $51,360 |
| 2026-03-27 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 4,933 | $0 |
| 2026-03-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 3,057 | $687,825 |
| 2026-03-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 2,405 | $222,823 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 1,607 | $93,993 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 买入 | 466 | $37,616 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 699 | $138,898 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 53 | $10,604 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 698 | $140,361 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 950 | $191,644 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 697 | $141,345 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 668 | $136,025 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 3,413 | $712,634 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 1,457 | $299,836 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 1,588 | $328,541 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 2,457 | $510,835 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | 卖出 | 743 | $152,122 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14